Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes

{ "Support for Caregivers of Patients with Cancer and Diabetes", "This study is looking into a program called enCompass Humana, which offers social support for family caregivers of adults with cancer and diabetes. The program provides up to eight coaching sessions with a caregiver coach, resource materials, and access to an online tool to help caregivers find resources. You would also receive a resource booklet from the American Cancer Society. Researchers want to see if this program is helpful and easy to use for caregivers. They will measure how acceptable the intervention is after 8 weeks. This study is currently enrolling English-speaking caregivers aged 18 to 99 who are providing unpaid care to an adult with cancer and/or diabetes.", "design": "This is an interventional study with a planned enrollment of 162 participants. It is a randomized feasibility study of a pilot-tested coaching and navigation program.", "commitments": "Participants will receive up to eight coaching sessions and resource materials. The acceptability of the intervention will be measured at 8 weeks.", "compensation": "Not stated in the trial record.", "follow_up": "The primary endpoint is measured at 8 weeks.", }

Study design: Not specified.
What's involved: Not specified in the trial record.
Compensation: Not stated in the trial record.
Follow-up: Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes

Recruiting

NAAges 18–99InterventionalSupportive care

UNC Lineberger Comprehensive Cancer Center

~162 participants

Updated 2026-08-10 on ClinicalTrials.gov

What's tested:Surveythe resource booklet from the American Cancer Society

At a glance

Recruiting sites

3 of 3 listed sites are recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Acceptability of the Intervention Measure (AIM)

Measured over 8 weeks

Conditions

Cancer

Diabetes

Where it's being run

3 sites across 3 states

Florida1

North Carolina1

Vermont1

Study leadership

Erin E Kent, PhD · PRINCIPAL_INVESTIGATOR · UNC Lineberger Comprehensive Cancer Center

Who to contact

Ashley Hanson

[email protected]

984-888-9244

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

English-speaking.

Ability to provide written or verbal informed consent to participate in the study;

Willing and able to comply with study procedures based on the judgment of the investigator or protocol designee;

Be at least 18 years of age at the time of consent; and

Identify as an informal (unpaid) caregiver for an adult with a stage II-IV cancer AND diabetes.

English-speaking

Ability to provide informed consent.

Be at least 18 years of age at the time of consent; and

Their identified caregiver is enrolled in the study

Diagnoses: (must have cancer and diabetes)

Have a cancer diagnosis for which they are being actively treated at one of the study sites

Have a cancer diagnosis, stage II-IV solid tumor or any hematologic malignancy

Receiving active cancer treatment s, not including hormonal therapy

Concurrent history of diabetes with need for ongoing management

Exclusion

Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;

Existence of another co-morbid disease other than diabetes, which in the opinion of the investigator, prohibits participation in the protocol;

Participation in the intervention development phase of this intervention

Self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;

Existence of other co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol;

Their caregiver does not enroll in the study or withdraws consent

What this trial measures

Acceptability of the Intervention Measure (AIM)8 weeks
The AIM is a 4-item, 5-point Likert scale that measures intervention acceptability. The scale measures each statement from 1, "Completely disagree," to 5, "Completely agree." Scale items are averaged to produce a mean score. The AIM takes approximately 2 minutes to complete by caregivers.

Trialytics